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Abstract 
Urinary tract infections (UTIs) are the major health problem of patients with diabetes mellitus 
(DM) in Yemen, due to treatments of UTIs are usually empirical without a urine culture, which 
guide to use an inappropriate therapy. So, the current study was designed to examine the 
microbial pathogens that caused UTIs in DM patients at Nasser hospital in Ibb city-Yemen. A 
case-control study was conducted by collecting one hundred and thirty urine samples from 
DM patients (100) and 30 healthy individuals kept as normal control (NC). All urine samples of 
DM patients and NC individuals were analyzed by direct examination and inoculated in 
different standard bacteriological media and biochemical tests for the diagnosis species of 
microbial pathogens (bacteria and fungi) were performed. The microscopic examinations of 
urine showed that the white blood (W.B.Cs) or pus cells, Red blood cells (R.B.Cs), epithelial 
cells, glucosuria, and bacteriuria were significantly increased in DM patients than NC ones. 
There were non-significant differences of fasting blood sugar (mean=175 ± 46.4 mg/dl) among 
DM patients. The incidence of microbial growth that caused UTIs in DM patients were (38%), 
including 10% in T1DM and 28% in T2DM, which was highly significant than those in NC 
(7%). Our findings showed a higher incidence of Gram-negative bacteria (60.5%) than gram-
positive bacteria (34.2%) and fungi (5.3%). Gram-negative species include Escherichia coli 
(18.4%), Klebsiella pneumoniae (13.1%), Neisseria gonorrhoeae (10.5), Pseudomonas 
aeroginosa (7.9%), Proteus mirabilis (5.3%), and Salmonella typhi (5.3%) while 
Staphylococcus aureus (15.8%), Streptococcus spp (10.5%) and Staphylococcus spp (7.9%) 
belong to gram-positive bacteria. The fungal isolates were of Candida albicans. Our results 
demonstrated that Escherichia coli and Staphylococcus aureus were more prevalent 
pathogens that caused UTIs in DM patients. 
Keywords: Diabetes mellitus, Urinary tract infections, Microbial pathogens, Yemen. 
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INTRODUCTION 
Diabetes mellitus (DM) is a highly prevalent worldwide 
health problem, with an expected prevalence of 593 million 
by 2035, particularly of type 2 diabetes mellitus (T2DM). 
Asia and Africa are designated as the greatest potential 
regions for this disorder. An association between urinary 
tract infections (UTIs) and DM was first recognized in an 
autopsy series reported in the 1940’s (Lahelma et al., 2004; 
Vaag, 2006; Janifer et al., 2009; Guariguata et al., 2014). 
DM causes changes in host defense mechanisms and 
neuropathy which impair bladder emptying and the 
presence of diabetic cystopathy and micro-vascular 
disease in diabetics’ patients’ kidneys. So, DM is a major 
risk factor for the higher incidence of UTIs in these patients, 
due to several mechanisms including: the presence of 
glycosuria, neutrophil dysfunction and increased adherence 
of the bacteria to uroepithelial cells, older ages, metabolic 
control, diabetic nephropathy, autonomic neuropathy and 
vascular complications (Boyko et al., 2002; Hakeem et al., 
2009; Mnif et al., 2009). 
UTIs are the most common infections among patients 
with DM and responsible for morbidity and mortality, due to 
cystitis, pyelonephritis, impaired leucocyte function, 
recurrent vaginitis, emphysematous complications and 
renal/perinephric abscesses, particularly, when glycemic 
control is poor and if UTIs are unrecognized or untreated in 
these patients (Patterson and Andriole, 1997; Mahesh et 
al., 2011; Prakasam et al., 2012; Alkhyat and Al.Maqtari, 
2014; Schneeberger et al., 2014).  
Other risk factors for UTIs among patients with and 
without DM were identified as: Obesity, female sex and 
prostate syndrome in men, glycosuria, low immunity and 
bladder dysfunction, UTIs are a relatively common problem 
that occurs in all age groups and observed most commonly 
among women than men, because of profound 
physiological, hormonal and anatomical changes during 
pregnancy (Nicolle, 2005; Funfstuck et al., 2012; Hamdan, 
2015; Rohini et al., 2017). 
Basically, UTIs are infections caused by the presence 
and growth of microorganisms in urinary tract, due to the 
enterance of bacteria from the digestive tract into the 
opening of the urethra, began to multiply and caused 
infections. Women are more susceptible to UTIs than men, 
due to short urethra, inability of women to empty their 
bladder completely, absence of prostatic secretion, 
pregnancy and the proximity of vagina and anus, which 
resulted the easy contamination of the urinary tract with 
fecal normal flora (Okonko et al., 2009; Haider et al., 2010). 
Variety of microorganisms, including fungi and viruses 
can cause UTIs, but bacteria are the most common 
pathogens, which are responsible for nearly 95 % of cases. 
E. coli is the more prevalent causative agent among 
bacteria and it is solely responsible for more than 80% of 
these infections (Papazafiropoulou et al., 2010; Pargavil et 
al., 2011; AL-Kadassy et al., 2016). 
Importantly, bacterial infections are a major problem in 
DM patients; these infections are caused by number of 
bacteria which include: Escherichia coli, Klebsiella 
pneumoniae, Proteus species, Staphylococcus aureus, 
Pseudomonas aeruginosa, Enterobacter, group B 
Streptococci, Enterococcus faecalis, Serratia species. The 
prevalence of bacteriuria is higher in diabetic women than 
in non-diabetic women, various risk factors for bacteriuria in 
women with diabetes include sexual intercourse, age, 
degree of glycosuria and duration of metabolic control, 
macro albuminuria, high body mass index (BMI) and 
complications of diabetes (Andriol, 2002; Harding et al., 
2003; Pargavil et al., 2011; Hoepelman et al., 2003). 
The most common etiological species of bacteriuria in 
diabetic women include Escherichia coli, Proteus mirabilis, 
Klebsiella pneumonia, Staphylococcus aureus, group B 
Streptococcus, Staphylococcus saprophyticus, the 
erroneous of current therapy for UTIs is usually use of 
empirical treatment without the a urine culture and 
susceptibility testing, so, antimicrobial resistance was 
increased worldwide for the most microbial pathogens that 
caused UTIs and treatments  become a major health 
problem in these patients  (Gupta et al.,2001; Al-Haddad, 
2005; Mordi, 2006; Ghenghesh et al.,2009; 
Papazafiropoulou et al., 2010; Chakupurakal et al.,2011; 
Lucas et al., 2015). 
 Indeed, the main risk factors of UTIs in developing 
country, including our country “Yemen”  are : Poor or 
inadequate personal hygiene, lower socioeconomic of 
population, lower socioeconomic population, sexual 
activity, the use of certain contraceptive methods  and 
increase antimicrobial resistance (Lucas et al., 2015 , AL-
Kadassy et al., 2016).  
Finally, Yemen is currently undergoing the rapid 
increase in the incidence of diabetes, in the year 2000, the 
prevalence of diabetes in the whole of Yemen increased 
from 4.7 to 6.57 % , in 2004, the total prevalence T2DM in 
the urban cities of Yemen was about 4.6 % (4.6 % of males 
and 2 % of females) and  in 2008, the incidence of diabetes 
in Yemen had increased to 10.4 %. Furthermore, the 
prevalence of impaired glucose tolerance (IGT) and 
impaired fasting glucose (IFG) were found to be 2 and 2.2 
%, respectively. Other reports indicated the UTIs were 
increased in Yemeni diabetic female: obese and BMI 
higher than male patients (Gunaid et al., 1997; Gunaid, 
2002; Kholood et al., 2003; Al-Habori et al., 2004; Al-
Haddad, 2005; Gunaid and Assabri, 2008 ). 
This study was aimed to determine the outcome of 
microbial pathogens that causing UTIs in DM patients and 
explore the association of risk factors (age, sex, duration of 
disease and blood glucose levels) with these patients , 
which attending to Nasser hospital, Ibb city, Yemen. 
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MATERIALS AND METHODS 
This case-control study was approved by the 
institutional research committee and anonymity of patients 
was protected. Urine samples from DM patients (100) and 
NC individuals (30) at morning from midstream were 
collected in a sterile and dry container for each. All samples 
were labeled and subjected immediately to macroscopic 
and microscopic examination. Then bacterial culture were 
done for all DM patients and NC individuals in Nutrient, 
Blood and MacConkey, Cysteine lactose electrolyte 
deficient (CLED), Sabouraud dextrose (SDA) agars 
(HiMedia, India), then incubated aerobically at 37°C for 24–
48 hours. The sub-culturing of bacterial isolates on a 
suitable media for confirmation and identification of bacteria 
in positive cultures based on known standard methods was 
done. These include Gram staining of smears, biochemical 
tests relevant to these isolates, included: Kligler iron agar 
(KIA), indole, motility, citrate and methyl red tests and the 
routine bench tests such as: catalase, oxidase and 
coagulase tests were done. Finally, the fasting blood sugar 
levels were detected according manufactured kit. 
                               
RESULTS AND DISCUSSION 
Our findings showed that among one hundred DM 
patients, males were 37% and females were 63% and 
classified into four groups: Group I, 4-19 years, represented 
6%; Group II, 20-39 years, represented 14%; Group III, 40-
59 years, represented 61%; Group IV, 60-84 years, and 
represented 19%. While among thirty healthy individuals as 
NC; 40% were male and 60% females. Our results showed 
that DM significantly increased in older patients, 61% 
patients belong to age group 40-59 years. There was no 
significant difference among DM patients regarding the 
fasting blood sugar and mean value was 175 ± 46.4 mg/dl. 
T2DM was more significantly prevalent (71%) than T1DM 
(29%). DM was more prevalent among women (19% 
T1DM and 44% T2DM), than diabetic men (10% T1DM 
and 27% T2DM), as shown in Table 1. 
 
 
 
Table 1. Demographics characters of diabetes mellitus (DM) patients and Normal Control (NC).  
Characters Diabetes mellitus (DM) patients Normal Control (NC). 
Ages and Sexes N (%) 
     Group I:4-19 Years. 
     Group II:20-39 Years. 
     Group III:40-59 Years. 
     Group IV:60-84 Years 
                 Total        
Male                    Female            Total 
2 (2%)                 4 (4%)                6 (6%) 
4 (4%)                10 (10%)            14 (14%) 
21 (21%)* *         40 (40%)            61 (61%) 
10 (10%) *          9 (9%)                19 (19%) 
37 (37%)            63 (63%) **        100 (100%) 
 Male                 Female               Total 
2 (6.7%)            3 (10%)           5 (16.7%) 
1 (3.3%)            5 (16.7 %)       6 (20%) 
4 (13.3%)          6 (20%)           10 (33.3%) 
5 (16.7%)          4 (13.3%)         9 (30%) 
12 (40%)            18 (60%)         30 (100%) 
Types of diabetes mellitus N(%) 
     Type 1 diabetes mellitus  
          (T1DM) 
   Type 2 diabetes mellitus  
        (T2DM) 
               
         Total            
 
  
10 (10%)             19(19%)              29 (29%)  
    
27 (27%)             44(44%)              71 (71%)** 
 
37 (37%)             63(63%)             100 (100%) 
 
 
 
- 
- 
 
- 
Duration of diabetes mellitus 
           
          Group I                                   
          Group II 
          Group III 
          Group IV 
 
(Mean +SD) years 
2.3 ± 1.5 
4.2* ± 3.6 
5.1* ± 4.8 
7.3** ± 5.2 
 
 
- 
- 
- 
- 
Fasting Blood Sugar  
  Concentration  
              Group I 
              Group II 
              Group III 
              Group IV  
              Mean  
 
(Mean +SD) (mg/dl) 
176  ±  59.5 
172  ±  46.3 
174  ±  46.7 
178  ±  33.2 
175  ±  46.4 
 
 
- 
- 
- 
- 
*P˂0.05  , **P˂0.01 
 
 
 
Our results of urine direct examination showed a 
significant difference between DM patients and NC 
individuals, the mean numbers of WBCs, red blood cells 
and epithelial cells were higher in DM patients than in NC, 
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the percentages of glycosuria and bacteriuria in DM 
patients were 40% and 27% respectively (Table 2). Our 
results showed that 38% DM patients showed microbial 
pathogens growth including 10% in T1DM and 28% in 
T2DM, which was highly significant than those in NC (7%). 
(Figure 1). 
 
Table 2. Microscopic examination of urine in diabetes 
mellitus patients and healthy individuals. 
     Tests  Diabetes 
mellitus patients 
Healthy 
individuals 
W.B.Cs.*103 cells 
(mean +SD) 
5.3 ± 3.6**  2.4 ± 2.2 
R.B.Cs*106 cells 
(mean +SD) 
1.8 ± 1.5* 1.3 ± 1.1 
Epithelial cells.(mean 
+SD) 
4.8 ± 3.2** 2.2 ± 0.9 
Glucosuria N(%) 40 (40%)** 5  (17%) 
Bacteriuria N(%) 27 (27%)** 3  (10%) 
*P˂0.05, **P˂0.01 
 
 
 
 
Fig. 1. Distribution of the percentages of microbial 
growth in DM (T1DM, T2DM) patients and normal 
control (NC). 
 
Our findings showed a higher incidence of Gram-
negative bacteria (60.5%) than gram-positive bacteria 
(34.2%) and fungi (5.3%). Gram-negative species include 
Escherichia coli (18.4%), Klebsiella pneumoniae (13.1%), 
Neisseria gonorrhoeae (10.5), Pseudomonas aeroginosa 
(7.9%), Proteus mirabilis (5.3%), and Salmonella typhi 
(5.3%) while Staphylococcus aureus (15.8%), 
Streptococcus spp (10.5%) and Staphylococcus spp 
(7.9%) belong to gram-positive bacteria. The fungal 
isolates were of Candida albicans. Our results 
demonstrated that Escherichia coli and Staphylococcus 
aureus were more prevalent pathogens that caused UTIs in 
DM patients (Figure 2). 
 
 
 
Fig. 2. The outcome of urinary tract infections (UTIs) 
among diabetes mellitus patients. 
 
DISCUSSION 
DM is a metabolic disorder resulting from a defect in 
insulin secretion and insulin action or both. Insulin 
deficiency leads to chronic hyperglycemia with 
disturbances of carbohydrate, fat and protein metabolism. 
Most of DM cases occur as a result of rise in developing 
countries, so, these countries will bear the brunt of DM 
epidemic to the extent of 77% of the global burden in the 
21st century. International Diabetes Federation Association 
(IDFA) in 2011 estimated 366 million people suffer from DM 
and the number is expected to rise to 552 million by 2030 
(Conget, 2002; Cho et al., 2006; Nandeshwar et al., 2010; 
Megerssa et al., 2010). 
UTIs are documented as an inflammatory response of 
the uro-epithelium by bacterial invasion that are usually 
associated with bacteruria and pyuria. UTIs are the second 
most common site for bacterial infection in human,  
bacterial virulence factors play a subsidiary part in the 
genesis of disease, which occur in the presence of 
anatomic or function abnormalities in the kidney, bladder or 
collecting systems: obstruction to normal urine flow, 
including (renal, ureteric and bladder calculi and benign 
prostatic hypertrophy), cystic renal disease, specific 
diseases like, DM, abnormalities in host defense 
mechanisms and those infections that follow surgery or 
procedures done in urinary tract (Sibi et al., 2011; Natesan 
and Thasneem, 2017). 
In diabetic patients, screening for UTIs is very 
important to enable doctors to properly treat it and to 
prevent the development of possible complications, 
0%
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including bacteremia, renal abscess and renal papillary 
necrosis. In general, UTIs are frequent causes of morbidity 
and mortality in diabetic patients, which due to immunologic 
defects contribute to the increased risk for infection: 
impaired neutrophil function, low levels of prostaglandin E, 
thromboxane B2, leukotriene B4, decreased T-cell-
mediated immune response (Geerling, 2008). 
Our results showed that UTIs were more prevalent in 
females than males of DM patients, also, the duration of 
DM disease increased with older patients at 40-59 years. 
These results were in agreement with other studies that 
demonstrated that UTIs were more prevalent in female 
than men of DM patients. Also, our results are similar to 
many previous studies that indicated the older age, 
duration of DM disease and glucose levels in DM are risk 
factors for UTIs among diabetic patients (Patterson and 
Andriole, 1997; Hammar et al., 2010; Emiru et al., 2013; Al-
Hadad, 2005; Alsamarai et al., 2011). In addition, others 
suggested that in diabetic patients, specific risk factors for 
UTI are usually the duration of diabetes and the presence 
of long-term complications, such as neuropathy, rather than 
current glucose control (Geerlings et al., 2000; Gorter et al., 
2010).  
On the other hand our findings disagree with other 
reports that showed no association between duration of 
DM disease and UTIs, the susceptibility of diabetic patients 
to UTIs could be explained by diminished neutrophil 
response, lower urinary cytokines and leukocyte 
concentrations, which might facilitate the adhesion of 
microorganisms to uroepithelial cells, also, sexual 
intercourse was reported as a risk factor for UTIs in women 
regardless of their DM status (Brown et al., 2005; Lin et al., 
2012; Muller et al., 2005; Geerlings et al., 2000; Scholes et 
al., 2005). 
Our results showed that T2DM was more prevalent 
than T1DM. These results were similar with other reports, 
which illustrated that DM is the commonest metabolic 
abnormality in the world; T2DM is the commonest form of 
diabetes constituting nearly 90% of the diabetic population 
(Ramachandran and Snehalatha, 1999; Sharlin et al., 
2015). A study reported the prevalence of diabetes to be 
34.80%, prevalence in women was calculated to be 
31.20% and in males 40.40% (Muhammad et al., 2013). 
Our results about microscopic examination of urine 
showed that the white blood (WBCs) or (pus) cells, Red 
blood cells (R.B.Cs), epithelial, glucosuria and bacteriuria 
were increased in DM patients than NC individuals. These 
results were in agreement with others, who showed the 
conditions such as incomplete bladder emptying due to 
autonomic neuropathy and high glucose concentration in 
the urine allow urinary colonization by microorganisms, the 
presence of bacteria in urine “bacteriuria”, evidenced that 
patients with diabetes have an increased risk of 
asymptomatic bacteria and UTIs, bacterial infections were 
the most common infections in diabetic patients. Other 
study showed that Patients with diabetes have a 10-30 fold 
increased risk of UTIs when compared to non-diabetics 
(Goswani et al., 2001; Hong, 2006; Bonadio et al., 2006). 
Other researchers reported that about half of adult diabetic 
women have higher incidence of bacteriuria and 
asymptomatic UTIs at some stage throughout their life and 
tend to increase with age (Raz and Stamm, 1992; 
Geerlings, 2008; Janifer et al., 2009). Previous studies 
documented that there is a relationship between bacteriuria 
and positive urine culture, T2DM patient’s urine culture was 
positive in patient with bacteriuria. Patients with UTIs more 
likely to have leukocyturia, while a normal leukocyte count 
predicted the absence of UTI in 96% of the women 
(Lerman-Garber et al., 2000; Tahir and Uddin, 2009). 
Other studies revealed that the microscopic 
examination of urine samples have pus cells or W.B.Cs, 
RBCs, epithelial cells and Schistsoma haematobium, 
respectively positive in DM patients and they found a heavy 
and appreciable bacterial growth in patients with 
bacteriuria, while no appreciable bacterial growth in other 
patients without bacteriuria from all collected urine samples 
among diabetic pregnant women (El-Sokkary, 2011; 
Fareid, 2012). These findings about the presence of 
bacterial growth in DM patients were in agreement with 
many studies that reported a high prevalence of UTIs in 
DM patients than those non-diabetics ones, particularly, 
T2DM patients (Jackson et al., 2004; Boyko et al., 2005; 
Hirji et al., 2012; Fu et al., 2014). 
Finally, our results showed a higher incidence of 
Gram-negative bacteria than gram-positive bacteria and 
fungi. UTIs are more common in diabetic females because 
of a combination of host and local risk factors, the principal 
causative agents accounting for 85% of cases of UTI are 
enteric G-ve bacteria. Other studies reported that the most 
frequent fungal infection is caused by Candida albicans, 
also UTIs can be caused by viruses (Numazaki et al., 1973; 
Davies et al., 1979; Tolk et al., 1980; Gruneberg, 1980; 
Goswami et al., 2001; Mansoor et al., 2015). A previous 
study in Pakistan reported the incidence of Escherichia coli 
(80%), followed by Staphylococcus aureus (6%), Klebsiella 
sp. (6%), Pseudomonas sp. (4%) and Proteus sp. (4%) in 
UTIs (Ashraf, 2014). 
Many studies reported that E. coli remains the most 
common etiological agent of UTIs. E. coli is a bacterium of 
the digestive tract; it can spread, especially, in women for 
anatomical reasons: down to the anus and then back in the 
urinary tract by multiplying and causing UTIs. Moreover, E. 
coli and G+ve bacteria, included: Staphylococcus aureus, 
Staphylococcus spp, were found to be the common 
uropathogen in diabetic patients than those without 
diabetes. Additionally, these findings are consistent with 
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others, who reported that UTIs cause considerable 
morbidity and mortality in patients with DM, the successful 
management of UTIs in diabetic patients depends on the 
proper identification of the types of pathogenic bacteria and 
the selection of effective antibiotics against them (Goswami 
et al., 2001; Salvatore et al., 2011; A-Ameri et al., 2014; 
Abdulla et al., 2015; Chentouf et al., 2015). 
 
CONCLUSION 
Our findings indicated that UTIs were more prevalent 
among diabetics than non-diabetics individuals and more 
frequent in T2DM thanT1DM patients. Also, UTIs were 
more frequent among diabetics’ women than men. The G-
ve bacteria are the most microbial pathogens that caused 
UTIs in DM patients, particularly, Escherichia coli is the 
commonest pathogen isolated in DM patients with UTIs 
followed by G+ve bacteria Staphylococcus aureus and 
Candida albicans. There were non-significant differences 
for fasting blood sugar, so we recommended to perform 
glycosylated haemoglobin (HbA1C) which serves as an 
estimator for the levels of blood glucose and it correlate 
with microbial infections in DM patients. Finally, an ongoing 
screening of UTIs should be encouraged for an updated 
knowledge about the uropathogens that causing infections 
and to inform about the emerging antibiotic resistance in 
different areas in our country “Yemen”.  
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